14Dec 2022
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

The objective of this study was to examine long-term outcomes among children newly diagnosed with cancer who were treated in dexrazoxane-containing clinical trials. Osteosarcoma survivors from the Childhood Cancer Survivor Study (CCSS; n = 495; no dexrazoxane) served as comparators in subanalyses. Follow-up events were assessed with cumulative incidence, Cox regression, and Fine-Gray methods.Dexrazoxane did not appear to adversely affect long-term mortality, event-free survival, or second cancer risk.

  • #oncology

Like

Save

Share